全文获取类型
收费全文 | 5142篇 |
免费 | 48篇 |
国内免费 | 2篇 |
专业分类
电工技术 | 33篇 |
化学工业 | 300篇 |
金属工艺 | 31篇 |
机械仪表 | 21篇 |
建筑科学 | 40篇 |
矿业工程 | 2篇 |
能源动力 | 28篇 |
轻工业 | 258篇 |
水利工程 | 7篇 |
石油天然气 | 3篇 |
无线电 | 248篇 |
一般工业技术 | 362篇 |
冶金工业 | 3576篇 |
原子能技术 | 33篇 |
自动化技术 | 250篇 |
出版年
2021年 | 31篇 |
2020年 | 17篇 |
2019年 | 27篇 |
2018年 | 32篇 |
2017年 | 32篇 |
2016年 | 30篇 |
2015年 | 23篇 |
2014年 | 36篇 |
2013年 | 107篇 |
2012年 | 57篇 |
2011年 | 83篇 |
2010年 | 52篇 |
2009年 | 65篇 |
2008年 | 80篇 |
2007年 | 50篇 |
2006年 | 73篇 |
2005年 | 66篇 |
2004年 | 39篇 |
2003年 | 49篇 |
2002年 | 39篇 |
2001年 | 53篇 |
2000年 | 40篇 |
1999年 | 137篇 |
1998年 | 1028篇 |
1997年 | 622篇 |
1996年 | 399篇 |
1995年 | 226篇 |
1994年 | 209篇 |
1993年 | 255篇 |
1992年 | 74篇 |
1991年 | 57篇 |
1990年 | 73篇 |
1989年 | 71篇 |
1988年 | 76篇 |
1987年 | 63篇 |
1986年 | 55篇 |
1985年 | 55篇 |
1984年 | 23篇 |
1983年 | 24篇 |
1982年 | 34篇 |
1981年 | 36篇 |
1980年 | 52篇 |
1978年 | 27篇 |
1977年 | 93篇 |
1976年 | 225篇 |
1975年 | 30篇 |
1974年 | 14篇 |
1973年 | 15篇 |
1972年 | 15篇 |
1970年 | 14篇 |
排序方式: 共有5192条查询结果,搜索用时 109 毫秒
61.
62.
M. Reischmann R. Merz L. Schultz L. E. Weiss 《e & i Elektrotechnik und Informationstechnik》2002,119(7-8):248-252
In the course of the research described in this paper a prototype assembly system for the automated fabrication of customized, biodegradable bone implants for tissue engineering applications has been developed. This work is part of a collaborative effort between the Handling Laboratory (hLab) of Fachhochschule Vorarlberg and the Bone Tissue Engineering Center (BETC) of Carnegie Mellon University. Bone implants are built up using thin layers of highly porous, biodegradable polymer scaffold materials. These layers can be seeded with cells prior to assembly. The main focus of this work is robotic handling of the prefabricated polymer layers. Additional components that are addressed include the cutting of contoured polymer layers from sheetstock and the assembly of the 21/2 dimensional layers to form 3D bone implants. Cutting tests have been performed to assess different cutting technologies. Assembly tests with mechanical connectors and fibrin adhesive have also been conducted. These components are integrated within a robot cell to demonstrate overall system feasibility. 相似文献
63.
64.
65.
66.
SI Chowdhury BJ Lee D Mosier JH Sur FA Osorio G Kennedy ML Weiss 《Canadian Metallurgical Quarterly》1997,117(4):295-310
CI-994 (acetyldinaline) is an orally active anticancer drug currently in Phase 1 clinical trials. To assess its preclinical toxicity, CI-994 was administered orally as suspensions to Wistar rats (10/sex/dose) and in capsules to beagle dogs (3/sex/dose) once daily for two weeks. Doses were 1.5, 5, and 15 mg/kg for rats (9, 30, and 90 mg/m2, respectively), and 0.5, 2, and 5 mg/kg for dogs (10, 40, and 100 mg/m2, respectively). Systemic exposure was dose-proportional based on toxicokinetic analysis in dogs. Severe clinical signs and mortality occurred at the highest dose in both species beginning on Day 10. Neutropenia, lymphocytopenia, thrombocytopenia, lymphoid depletion, bone marrow hypocellularity, and testicular degeneration were observed in both species, primarily at the mid- and high-doses. Despite continued treatment, neutrophil counts in dogs returned to control levels in Week 2. Other microscopic findings in rats included splenic hematopoietic depletion at all doses and epithelial cell necrosis in various tissues at 15 mg/kg. Additional bone marrow changes in dogs involved myeloid and megakaryocyte hyperplasia at 2 mg/kg and abnormal myeloid and megakaryocyte maturation at 2 and 5 mg/kg. Except for the testicular effects in both species, all changes were reversible within a 4-week (rat) or 9-week (dog) recovery period. The results of these studies show that target organ effects of CI-994 principally involve tissues with rapidly dividing cell populations and that bone marrow suppression is the dose-limiting toxicity. CI-994 also seems to interfere with the release and/or maturation of cells in the bone marrow. 相似文献
67.
MG Narducci L Virgilio JB Engiles AM Buchberg L Billips A Facchiano CM Croce G Russo JL Rothstein 《Canadian Metallurgical Quarterly》1997,15(8):919-926
In human leukemias and lymphomas nonrandom chromosomal rearrangements cause changes in cell growth and/or survival in such a way as to promote malignancy. The detailed study of the biochemical and genetic pathways altered in human cancer requires the identification or development of models to allow the study and manipulation of cancer gene function. Recently, the breakpoint gene TCL1, involved in chromosome translocations observed mostly in mature T-cell proliferations and chronic lymphocytic leukemias (CLL), was isolated and characterized, and showed to be part of a new gene family of proteins involved in these tumors. The murine Tcl1 gene, is similar in sequence to the murine and human MTCP1 gene also involved in T cell leukemias. The murine Tcl1 gene was shown to reside on mouse chromosome 12 in a region syntenic to human chromosome 14. Furthermore, we show that the murine Tcl1 gene is expressed early in mouse embryonic development and demonstrates expression in fetal hematopoietic organs as well as in immature T and B cells. Characterization of the murine Tcl1 gene will help in developing a mouse model of CLL and would provide the best opportunity to study and decipher the role of TCL1 in malignant transformation. 相似文献
68.
69.
RP Whitehead J Jacobson TD Brown SA Taylor GR Weiss JS Macdonald 《Canadian Metallurgical Quarterly》1997,15(6):2414-2419
PURPOSE: Pancreatic cancer is difficult to treat, with most patients surgically unresectable at the time of diagnosis. Radiotherapy and chemotherapy can offer palliation, but more effective therapy is needed. This trial evaluated the effects of an aggressive schedule of paclitaxel given with granulocyte colony-stimulating factor (G-CSF) to patients with advanced pancreatic cancer. PATIENTS AND METHODS: All patients were required to have a histologic diagnosis of pancreatic adenocarcinoma with measurable disease and no prior chemotherapy or radiation therapy. Patients had to have performance status of 0 to 2, pretreatment absolute granulocyte count > or = 1,500/microL, and platelet count greater than or equal to the institutional lower limit of normal. Following pretreatment with dexamethasone, diphenhydramine, and cimetidine, patients received paclitaxel at a dose of 250 mg/m2 by 24-hour infusion on day 1, repeated every 21 days. G-CSF was given at a dose of 5 microg/kg/d on days 3 to 18 or until two consecutive absolute neutrophil counts (ANCs) > or = 10,000/microL were obtained. Doses of paclitaxel were modified depending on nadir counts. RESULTS: Forty-five patients were entered onto this study, with six ineligible. For the 39 eligible patients, there was one complete response (CR) and two partial responses (PRs), five stable/no responses, 23 increasing disease, two early deaths, and six patients whose assessment was inadequate to determine response. The response rate was therefore three of 39 or 8% (95% confidence interval [CI], 2% to 21%). The median survival time for the 39 eligible patients was 5 months. The most common toxicities were anemia, leukopenia/granulocytopenia, malaise/fatigue, nausea/vomiting, alopecia, thrombocytopenia, paresthesias, and liver function abnormalities. There was one death due to sepsis. CONCLUSION: Single-agent paclitaxel in this dose and schedule has minimal activity in pancreatic adenocarcinoma patients. 相似文献
70.
J Svanegaard JB Johansen P Thayssen T Haghfelt 《Canadian Metallurgical Quarterly》1993,155(23):1784-1788
The maintenance of cardiac pumping ability in the presence of a primary disturbance of myocardial contractility and/or an excessive haemodynamic strain on the heart is dependent on several compensatory mechanisms. Particular attention has formerly been paid to the importance of the Frank-Starling mechanism and cardiac hypertrophy and dilatation in maintaining a blood supply sufficient to cover the metabolic needs of various tissues in heart failure. In recent years, however, it has been found that certain neurohormonal systems (the sympathetic nervous system, the renin-angiotensin-aldosterone system, atrial natriuretic peptide and several locally acting vaso-active substances) undergo considerable changes according to the degree of heart failure. These compensatory mechanisms support the circulation wholly or partially in acute heart failure, however sustained neurohormonal activation may be harmful in chronic heart failure, where several neurohormonal factors may be activated to ill-effect. The most significant neurohormonal systems and their importance in heart failure are reviewed on the basis of the available literature. 相似文献